ZTS Logo

Zoetis Inc. (ZTS) 

NYSE
Market Cap
$74.15B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
496 of 960
Rank in Industry
27 of 59

Largest Insider Buys in Sector

ZTS Stock Price History Chart

ZTS Stock Performance

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives …

Insider Activity of Zoetis Inc.

Over the last 12 months, insiders at Zoetis Inc. have bought $0 and sold $4.55M worth of Zoetis Inc. stock.

On average, over the past 5 years, insiders at Zoetis Inc. have bought $2.5M and sold $76.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 15,180 shares for transaction amount of $2.5M was made by SCULLY ROBERT W (director) on 2021‑02‑19.

List of Insider Buy and Sell Transactions, Zoetis Inc.

2024-11-25SaleExecutive Vice President
3,477
0.0008%
$177.46$617,028-1.19%
2024-04-18SaleExecutive Vice President
923
0.0002%
$151.17$139,530+15.66%
2024-03-18SaleExecutive Vice President
923
0.0002%
$173.33$159,984+3.11%
2024-03-11Saledirector
1,370
0.0003%
$182.68$250,265-4.16%
2024-02-20SaleChief Executive Officer
13,000
0.0028%
$187.20$2.43M-5.24%
2024-02-20SaleExecutive Vice President
923
0.0002%
$187.30$172,878-5.24%
2024-02-13SaleExecutive Vice President
2,848
0.0006%
$186.86$532,177-3.64%
2024-02-12SaleExecutive Vice President
363
<0.0001%
$197.74$71,780-10.08%
2024-01-18SaleExecutive Vice President
923
0.0002%
$191.43$176,690-6.45%
2023-12-18SaleExecutive Vice President
923
0.0002%
$198.14$182,883-7.95%
2023-12-14SaleExecutive Vice President
2,500
0.0005%
$200.00$500,000-9.11%
2023-11-21SaleChief Executive Officer
13,000
0.0028%
$176.84$2.3M+1.59%
2023-11-17SaleExecutive Vice President
923
0.0002%
$177.46$163,796+4.24%
2023-10-18SaleExecutive Vice President
923
0.0002%
$172.92$159,605+7.02%
2023-09-18SaleExecutive Vice President
923
0.0002%
$179.58$165,752-1.50%
2023-09-15SaleExecutive Vice President
9,905
0.0022%
$180.15$1.78M-1.85%
2023-09-01SaleExecutive Vice President
923
0.0002%
$192.97$178,111-8.10%
2023-08-22SaleChief Executive Officer
13,000
0.0028%
$179.97$2.34M-2.67%
2023-08-09SaleExecutive Vice President
1,179
0.0003%
$189.94$223,939-5.93%
2023-05-23SaleChief Executive Officer
13,000
0.0029%
$176.56$2.3M+2.02%

Insider Historical Profitability

4.77%
Lagano RoxanneExecutive Vice President
14800
0.0033%
$164.36139+3.04%
Pershing Square Capital Management, L.P.director
24973145
5.5353%
$164.3612<0.0001%
Knupp Catherine A.Executive Vice President
43642
0.0097%
$164.3618+3.04%
Lewis Clinton A. Jr.Executive Vice President
27904
0.0062%
$164.36112+3.04%
Chen Heidi C.Executive Vice President
27478
0.0061%
$164.36127+3.04%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$6.9B8.9340.75M+1.03%+$70.16M0.13
BlackRock$6.22B8.0536.73M+0.65%+$40.19M0.14
State Street$3.31B4.2919.57M+1.28%+$41.93M0.14
State Farm$2.73B3.5416.15M-1.18%-$32.69M2.46
Bank of America$2.36B3.0613.96M+3.39%+$77.38M0.23
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.